Christoferson Meat Company Inc. dba Raws for Paws LLC
Letter data
- Company
- Christoferson Meat Company Inc. dba Raws for Paws LLC
- Recipient
- Mark G. Mann | Owner | Christoferson Meat Company Inc. dba Raws for Paws LLC | 2700 26th Avenue South | Minneapolis | , | MN | 55406 | United States
- Issue date
- 2019-06-11
- Posted date
- Not available
- FDA office
- Division of Compliance
- Subject
- Not available
- Product
- Animal & Veterinary
- CMS ID
- 555466
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Christoferson Meat Company Inc. dba Raws for Paws LLC
MARCS-CMS 555466 —
June 11, 2019
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
Overnight Delivery
Product:
Animal & Veterinary
Recipient:
Recipient Name
Mark G. Mann
Recipient Title
Owner
Christoferson Meat Company Inc. dba Raws for Paws LLC
2700 26th Avenue South
Minneapolis
,
MN
55406
United States
Issuing Office:
Division of Compliance
7519 Standish Place
Rockville
,
MD
20855
United States
Dear Mr. Mann:
The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter, dated October 25, 2018. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter by discontinuing the manufacturing and distribution of raw pet food. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory actions should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Eric M. Nelson
Director, Division of Compliance
Center for Veterinary Medicine
Content current as of:
05/21/2020
Regulated Product(s)
Animal & Veterinary